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Edited by Vladimir SkulachevAbstract NDRG1 is a hypoxia-inducible protein, whose modu-
lated expression is associated with the progression of human can-
cers. Here, we reveal that NDRG1 is markedly upregulated in
the cytoplasm and on the membrane in human hepatocellular
carcinoma (HCC). We demonstrate further that hypoxic stress
increases the cytoplasmic expression of NDRG1 in vitro, but
does not result in its localization on the plasma membrane. How-
ever, grown within an HCC-xenograft in vivo, cells express
NDRG1 in the cytoplasm and on the plasma membrane. In con-
clusion, hypoxia is a potent inducer of NDRG1 in HCCs, albeit
requiring additional stimuli within the tumour microenvironment
for its recruitment to the membrane.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The N-myc downstream-regulated gene-1 (NDRG1) is a no-
vel protein initially described as a stress-responsive protein and
as being involved in cellular diﬀerentiation events [1–3]. Cur-
rent studies indicate that its putative biological function may
be as a tumour suppressor protein, and more speciﬁcally as
an inhibitor of tumour metastasis [3–8]. Paradoxically, ﬁndings
relating to the expression of NDRG1 are not always consistent
with this tenet. NDRG1 is commonly found to be expressed at
a higher level in cancerous than non-cancerous tissue of the
same origin, suggesting that the modulated expression of
NDRG1 may be tissue- or cell-type speciﬁc [9].Abbreviations: NDRG1, N-myc downstream regulated gene-1; HIF-1,
hypoxia-inducible factor-1; HCC, hepatocellular carcinoma; O2, oxy-
gen; siRNA, short-interfering RNA; DMOG, dimethyloxallyl glycine;
GSK3, glycogen synthase kinase 3; SGK-1, serum- and glucocorticoid-
induced kinase 1
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doi:10.1016/j.febslet.2007.01.080NDRG1 is a physiological substrate for serum- and gluco-
corticoid-induced kinase 1 (SGK1) and glycogen synthase ki-
nase 3 (GSK3) [20]. It is phosphorylated on several residues
within three 10-amino acid tandem repeats located near its
C-terminus. The expression of NDRG1 can be altered by var-
ious physiological conditions and external stimuli, in particu-
lar, hypoxia is a key stimulus for its increased expression
[10,11]. Central to the regulation of hypoxia-inducible genes
is the heterodimeric transcription factor, hypoxia-inducible
factor (HIF)-1 [12]. HIF-1 is negatively-regulated at a normal
oxygen concentrations, whereas under hypoxic conditions, its
alpha-subunit is stabilized and is translocated to the nucleus,
where it binds to its b-subunit and activates the transcription
of its target genes [13–15].
Hypoxia is a common characteristic and a key stimulus in
the pathophysiology of many solid tumours including the
highly-aggressive, chemoresistant hepatocellular carcinomas
(HCCs) [16–18]. In the present study, we investigated the inﬂu-
ence of hypoxia on the expression and subcellular localization
of NDRG1 and phosphorylated-NDRG1 in HCC.2. Materials and methods
2.1. Tissue samples
Resected tissues were collected from patients at the Inselspital in
Bern, Switzerland in accordance with standard procedures which were
approved by an Institutional Review Board (approval no.:
1.05.01.30.17) and with the patient’s written consent. HCC samples
were graded 1–3 according to Edmondson and Steiner and according
to the classiﬁcations of the World Health Organization (n = 11). Hepa-
tic tissue taken from tumour-free resection margins served as normal
controls (n = 6).2.2. Antibodies, immuno-histochemistry and -ﬂuorescence
Antibodies were obtained from the following companies: NDRG1
and phosphorylated-NDRG1 (p3xThr 346, 356 and 366 ) (Kinasource
Limited, Scotland, UK), Sp1 and IjBa (both from Santa Cruz, USA),
E-cadherin (BD Biosciences), b-actin (Sigma) and HIF-1a (Novus Bio-
logicals). Formalin ﬁxed tissues sections (5-lm-thick) were pressure
cooked for 15 min in ChemMate Target Retrieval Solution (Dako-
Cytomation). Endogenous peroxidase was blocked with 3% H2O2 for
10 min and blocked with 1% normal rabbit serum (NRS). Sections
were incubated overnight at 4 C with the primary antibody and
immunoreactivity was detected using ABC kits (Vectastain) and 3,3 0-
diaminobenzidine as the peroxidase substrate or a FITC-conjugated
secondary antibody was used for ﬂuorescence microscopy. Cells were
grown on glass cover slips, ﬁxed in 4% PBS-buﬀered formaldehyde,blished by Elsevier B.V. All rights reserved.
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ined with a Leica DMRB microscope and documented using IM50
Leica imaging software.
2.3. Cells and culture conditions
The human HCC cell line, Hep3B, was purchased from the Euro-
pean Collection of Cell Cultures and cultured according to suggested
guidelines. Cells were incubated under either normoxic conditions
(21% O2), using a standard CO2 incubator, or hypoxic conditions
(1.5% O2), using a hypoxia workstation (Ruskinn Technology Limited,
West Yorkshire, UK). For a non-hypoxic stabilization of HIF-1a, the
cells were incubated in 125 lM dimethyloxallyl glycine [(DMOG),
Alexis Biochemicals] for 24 h at 21% O2. RNA oligonucleotides spe-
ciﬁc for HIF cDNA were designed with the aid of an online tool
(www.ambion.com/techlib/misc/silencer_siRNA_template.html). Dou-
ble-stranded short-interfering RNA (siRNA) was transfected into
Hep3B cells using the supplied Transfection Reagent. The eﬃciency
of RNA interference was determined by real-time PCR.
2.4. Protein isolation and Western blot analysis
For the detection of NDRG1, the total protein content of cells and
tissues was extracted using a RIPA lysis buﬀer and 1:100 dilution of a
protease inhibitor cocktail (Sigma). For the detection of HIF-1a in
cells and tissues, enriched nuclear–protein extracts were prepared as
previously described [19]. For cell fractionation, the ProteoExtract
Subcellular Proteome Extraction kit (Calbiochem) was used in accor-
dance with the manufacture’s instructions. All proteins were quantiﬁedBA
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Fig. 1. Expression of NDRG1 and HIF-1a in HCCs by immunohistochemi
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membrane localization of NDRG1 in a HCC tumour (mixed trabecular and
trabecular and acinar type, grade 2) for (D) cytoplasmic and membrane stain
control to illustrate the speciﬁcity of the reaction (200· magniﬁcation). (G
compared to normal liver tissue.using the BioRad Protein Assay (BioRad). Fifty micrograms of protein
were separated by SDS–PAGE, transferred to a nitrocellulose mem-
brane and analyzed by Western blotting using standard protocols. Sig-
nals were detected by enhanced chemiluminescence (LiteAblot,
Euroclone). For patient sample analysis, the average of three indepen-
dent protein concentration measurements was used for as an accurate
loading control, given that the expression of many housekeeping genes
are modiﬁed in cancerous tissues.2.5. Real-time RT-PCR
Total RNA was isolated with Trizol (Invitrogen) and 1 lg of total
RNA was reverse transcribed (Qiagen). Primers and FAM-labelled
probes were obtained from the Assay-on-Demand for human NDRG1
and HIF-1a and quantitative PCR was performed using an ABI 7700
Sequence Detection System (Applied Biosystems). The Ct values for
each target genes were standardized against ribosomal RNA (18S).
DDCt values were calculated by subtracting the DCt values of cells un-
der normoxia from the DCt value of cells under hypoxia. Fold in-
creases were calculated using the formula 2DDCt. All reactions were
performed in triplicate, and each experiment was conducted on at least
three independent occasions.2.6. Analysis of the NDRG1 sequence
The domain structure of NDRG1 (Accession No. NP_006087) was
determined using the Predict Protein database (http://www.predictpro-
tein.org). Subcellular localization of NDRG4 (Accession No.F
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lization of NDRG1 in a HCC tumour (trabecular type, grade 3) and (C)
acinar type, grade 2). (D–E) Serial sections of a HCC tumour (mixed
ing of NDRG1, (E) nuclear localization of HIF-1a, and (F) a negative
) Western blot analysis of HIF-1a and NDRG1 expression in HCC
S. Sibold et al. / FEBS Letters 581 (2007) 989–994 991AAH11795) was predicted from pTARGET database (http://bioinfor-
matics.albany.edu/~ptarget/). Sequence homology for NDRG1 and
NDRG4 were determined using the SIM alignment tool for proteins
(http://www.expasy.org/tools/sim-prot.html).
2.7. Hep3B liver-xenograft model
Experiments were performed according to the National Institute of
Health’s Guidelines for the Care and Use of Laboratory Animals and
with the approval of the local Animal Ethics Committee. Liver-tumour
xenografts were grown in 4-week-old, male nude mice [Hsd:Athymic
Nude-Foxn1nu (Harlan Netherlands)] by injecting one million Hep3B
into the subcapsular space of the left lateral liver lobe. After 7 weeks,
the animals were sacriﬁced and the tumours were excised for analysis.Fo
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Fig. 2. Hypoxia upregulates the expression of NDRG1 in a HIF-1 dependen
cells in response to hypoxia (1.5% O2). (B) Western blot analysis of NDRG1
total NDRG1 protein and lower panel: antibody against phospho-NDRG1.
control. (C) Western blot analysis for NDRG1 and HIF-1a of cells exposed
(42 kDa) and Sp1 (97 kDa) were used as loading controls. (D) Eﬀect of HIF-
mRNA expression. Hep3B cells were transfected with speciﬁc HIF-1a siRNA
exposure to 1.5% O2 for 16 h.3. Results
3.1. Expression and cellular localization of NDRG1 and HIF-1a
in human HCC
In normal liver tissue, NDRG1 protein was found to be
weakly expressed in the biliary epithelial cells, whereas the
hepatocytes were negative (Fig. 1A). In contrast, the cells of
HCCs were highly immunoreactive (Fig. 1B and C). Within
a single tumour, 50–90% of the tumour cells stained positive
for NDRG1 and various expression patterns were observed.
NDRG1 expression was found both in the cytoplasm2
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t manner. (A) Quantitative real-time RT-PCR for NDRG1 in Hep3B
in Hep3B cells in response to hypoxia. Upper panel: antibody against
Arrows indicate upper and lower bands. b-actin was used as a loading
either to N: 21% O2, H: 1.5% O2 or 125 lM DMOG for 24 h. b-Actin
1a gene silencing on HIF-1a (upper panel) and NDRG1 (lower panel)
(30 nM and 50 nM) and a control siRNA (50 nM) for 24 h followed by
992 S. Sibold et al. / FEBS Letters 581 (2007) 989–994(Fig. 1B) and on the membrane (Fig. 1C). Hypoxic stress is a
known inducer of NDRG1. By using HIF-1a as a marker for
tumour hypoxia, we demonstrated in serial sections of a HCC
tumour the concomitant expression of NDRG1 (Fig. 1D) and
HIF-1a (Fig. 1E). Furthermore, both HIF-1a and NDRG1
protein levels were substantially higher in HCCs than in nor-
mal hepatic tissue (Fig. 1G). These data reveal NDRG1 to
be markedly over-expressed in HCCs and to be located within
both the cytoplasm and the plasma membrane, and that its
expression is co-localized with the stabilization of HIF-1a.
3.2. Hypoxia upregulates the expression of NDRG1
in a HIF-1-dependent manner
To assess the eﬀect of hypoxia on the expression of NDRG1
in HCC cells in vitro, we used as a model the human HCC cell
line, Hep3B. Hypoxia (1.5% O2) induced an increase in the
mRNA level of NDRG1 after 1–3 h which increased to 30-fold
by 24 h (Fig. 2A). NDRG1 protein was detected as a doublet
when analyzed by Western blot using an antibody against
its total protein. The more rapidly migrating lower band in-
creased after 3 h of hypoxia, and continued to rise for up to
24 h (Fig. 2B, upper panel). The slower migrating upper band
also increased albeit only after 12 h at 1.5% O2. The decrease in
the electrophoretic mobility of the upper band possibly reﬂects
a C-terminal phosphorylation of NDRG1 by GSK3, as re-
cently shown for the cervical cancer cell line-HeLa [20]. To
determine the phosphorylation state of NDRG1, the same ex-
tracts where tested with an antibody raised against phosphor-
ylated NDRG1 at Thr 346, Thr 356 and Thr 366, which is
targeted by serum- and glucocorticoid-induced kinase 1 [20].
Phosphorylated NDRG1 was present in normoxic cells and
was detected at a similar molecular weight to that of the upper
band of the total protein. Both the upper and lower band in-
creased after 12–24 h at 1.5% O2 thus demonstrating a hypox-
ia-induced increase of phosphorylated NDRG1 protein by
SGK and GSK3 (Fig. 2B, lower panel).
Hypoxia can upregulate genes in a manner that is either
dependent upon or independent of HIF-1 [21]. To ascertain
whether the upregulation of NDRG1 in liver cells is a conse-
quence of HIF-1 activation, cells were treated with the non-128 143
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Fig. 3. Domain composition of NDRG1 gene. (A) Schematic representation
acids are indicated in bold and underlined. F, G, L, I and A represent ph
phosphorylated 10-amino acid tandem repeats located near the C-termin
hydrophobic regions.selective prolyl hydroxylase inhibitor, DMOG. Under nor-
moxia (21% O2), DMOG stabilized HIF-1a and resulted in
the simultaneous upregulation of NDRG1 (Fig. 2C). Further-
more, selective silencing of the HIF-1a gene with speciﬁc siR-
NA abolished the hypoxia-induced expression of NDRG1
mRNA in a dose-dependent manner (Fig. 2D). Taken
together, this shows that hypoxia and HIF-1 are strong tran-
scriptional inducers of NDRG1 in HCC cells.
3.3. Domain composition of NDRG1
We next analyzed the sequence of NDRG1 for domains
which would implicate it as a membrane-associated protein
(Fig. 1C). Within its sequence, we identiﬁed a highly hydro-
phobic 20-amino-acid sequence which represents either a po-
tential transmembrane domain or an anchor to the cytosolic
face of the lipid bi-layer (Fig. 3A). Its family member, NDRG4
is classiﬁed as a type II membrane protein (pTARGET analy-
sis gives 87.6% conﬁdence of plasma membrane localization).
A comparative sequence analysis of NDRG1 with NDRG4
revealed a 61% homology in the transmembrane domain iden-
tiﬁed in NDRG4 (Fig. 3B).
3.4. Subcellular localization of NDRG1 in response
to hypoxia in vitro and in vivo
NDRG1 expression has been described to be translocated
within the cell in response to exogenous stimuli [4]. We next
examined whether hypoxia induces a relocation of NDRG1,
in particular to its predominant localization site in HCC, the
plasma membrane. NDRG1 was ubiquitously expressed at a
low level in the cytoplasm of Hep3B cells under normoxic con-
ditions (Fig. 4A). After 24 h of hypoxic stress, the cytoplasmic
level of the NDRG1 increased, but did not translocate to the
plasma membrane (Fig. 4B). These results were conﬁrmed by
cell fractionation, NDRG1 was not detected in the membrane
fraction of either normoxic or hypoxic Hep3B cells (Fig. 4C).
An increased expression of both total and phosphorylated pro-
tein was detected in the cytoplasm of hypoxic cells.
To verify that the absence of NDRG1 on the plasma mem-
brane is not attributable to a defect in the traﬃcking machin-
ery in Hep3B cells, these cells were grown in vivo using anAL
AGAYILTRFAL150
AGAYVLAKFAL125
*************
GTR*pSRSH*pTSE3x
10 amino acid tandem repeat
339 369
of the putative domain composition of NDRG1. Hydrophobic amino
enylalanine, glycine, leucine, isoleucine and alanine, respectively. The
us are depicted. (B) Sequence homology of NDRG1 and NDRG4
A B
NNM MC C
Normoxia Hypoxia
Sp1
E-cadherin
I Bκ α
C
total NDRG1
phospho-NDRG1
D E F
NDRG1 phospho-NDRG1Negative
Control
Fig. 4. Localization of NDRG1 in Hep3B cells in vitro and in vivo. Immunoﬂuorescence NDRG1 expression in Hep3B cells grown in vitro under
(A) normoxia, 21% O2 or (B) hypoxia, 1.5% O2 for 24 h. (C) Proteins were isolated by cell fractionation from Hep3B cells cultured in vitro.
Antibodies against IjBa (40 kDa), E-cadherin (120 kDa) and Sp-1 (97 kDa) were used as markers for the cytoplasmic (C), the membrane (M) and the
nuclear (N) fractions, respectively. (D-F) Immunohistochemistry detection of NDRG1 (E) and phosphorylated NDRG1 (F) in Hep3B cells grown in
a mouse xenograft tumour in vivo. A negative control (D) illustrates the speciﬁcity of the reaction (200· magniﬁcation).
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an HCC-tumour environment showed increases in both the
cytoplasmic and the membrane levels of NDRG1 (Fig. 4E).
The pattern of expression in the murine xenografts was similar
to that in human HCCs and the surrounding murine hepatic
tissue displayed no immunoreactivity (data not shown). Fur-
thermore using a phospho-speciﬁc antibody, we observed
staining of phosphorylated NDRG1 predominately in the
cytoplasm of the tumour cells in vivo (Fig. 4F). These ﬁndings
demonstrate that NDRG1 can be translocated to the plasma
membrane of Hep3B cells in vivo, but not under the tested sig-
nalling conditions in vitro. Furthermore, hypoxia-induced
phosphorylation does not result in a membrane-associated
phosphorylated protein in vivo or in vitro, thereby suggesting
that tumour microenvironment harbours unidentiﬁed signals
that are required for translocation of NDRG1 to the plasma
membrane.4. Discussion
Either transiently or chronically, hypoxic stress is a common
characteristic of HCC tumours [22,23], therefore, we specu-
lated that the upregulation of NDRG1 in HCC could be med-
iated via the hypoxic activation of the HIF signalling pathway.
Here, we show in human HCC cells HIF-1a to be co-expressed
with NDRG1 in vivo and under conditions that are known to
activate HIF-1 in vitro (hypoxia or the presence of the prolyl
hydroxylase inhibitor (DMOG)). Taken together, this suggests
that one mechanism by which NDRG1 is overexpressed in
HCC is the activation of the HIF-1 signalling pathway. This
is in agreement with previous work, which proposed HIF-1
as a regulator of NDRG1 in human cancers [24].
In samples of human HCC which were analyzed by immuno-
histochemistry, NDRG1 expression was found in various sub-
cellular compartments. Its expression was located both in the
994 S. Sibold et al. / FEBS Letters 581 (2007) 989–994cytoplasm and on the plasma membrane. A comparative
sequence analysis yielded evidence for a putative membrane
association of NDRG1 protein. The factors that contribute
to the speciﬁcity of NDRG1 localization, and particularly to
its membrane targeting, are currently unknown, thus leading
us to examine the role of hypoxic stress. Our in vitro data con-
ﬁrms that hypoxia are a strong transcriptional upregulator of
NDRG1 expression. The hypoxia-induced expression of total
NDRG1 protein is followed by a subsequent increase of phor-
phorylated-NDRG1 on residues targeted by SGK1 [20]. Fur-
thermore, after prolonged hypoxia (12 h) there is also an
increase in GSK activity, evident by the increased expression
of the slower migrating phosphorylated band (Fig. 2B). This
is consistent with the work of Mottet et al., who reported that
prolonged hypoxia results in activation of GSK3 [25]. How-
ever, our data suggests that the hypoxia-induced increase of
NDRG1 and phosphorylated NDRG1 is not suﬃcient for its
membrane localization (Fig. 4C).
On the other hand, when cells were grown within an HCC-
tumour environment in vivo, a strong membrane localization
of total NDRG1 protein was observed. The membrane locali-
zation of total NDRG1 was not concomitant with its phos-
phorylated form. Phosphorylated NDRG1 was detected in
the cytoplasm of Hep3B cells grown in vivo as well as in the
cytoplasmic fraction of Hep3B cells cultured under hypoxic
stress in vitro (Fig. 4C). A similar expression pattern of phos-
phorylated NDRG1 was observed from patient samples of
HCC (data not shown). Although hypoxia is a key component
of the tumour microenvironment and can lead to the increase
of phosphorylated NDRG1, factors other than hypoxia are
critically involved in the re-distribution of NDRG1. Its expres-
sion on the plasma membrane within a neoplastic milieu
implies that NDRG1 may be involved in cell adhesion or cell
mobility or it may have a role in signal transduction, acting
as a signalling molecule regulated by phosphorylation. Further
insight into the relationship between NDRG1 and the tumour
stroma should improve our understanding of this protein’s role
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